Details for: NIT2
Associated with
Significant Cells
Cell Significance Index (CSI) scores for the chosen context(s)
-
CSI 13.76rCSI 11.96%PRS 72.6
-
CSI 11.21rCSI 11.72%PRS 59.91
-
CSI 7.53rCSI 10.26%PRS 53.69
-
CSI 7.46rCSI 5.21%PRS 64.66
-
CSI 6.46rCSI 6.22%PRS 61.91
-
CSI 5.39rCSI 3.75%PRS 73.02
-
CSI 5.37rCSI 4.45%PRS 61.1
-
CSI 4.75rCSI 11.59%PRS 55.43
-
CSI 4.7rCSI 5.91%PRS 73.65
-
CSI 4.41rCSI 3.28%PRS 75.19
-
CSI 4.23rCSI 6.2%PRS 73.45
-
CSI 3.94rCSI 8.8%PRS 69.66
-
CSI 3.76rCSI 9.06%PRS 79.49
-
CSI 3.65rCSI 4.69%PRS 59.02
-
CSI 3.45rCSI 6.71%PRS 64.86
-
CSI 3.43rCSI 21.42%PRS 53.76
-
CSI 3.38rCSI 4.24%PRS 72.28
-
CSI 3.25rCSI 3.77%PRS 69.37
-
CSI 3.08rCSI 2.14%PRS 77.07
-
CSI 3.01rCSI 7.07%PRS 66.64
-
CSI 2.9rCSI 2.44%PRS 78.79
-
CSI 2.87rCSI 3.92%PRS 67.86
-
CSI 2.71rCSI 4.36%PRS 51.4
-
CSI 2.71rCSI 4.16%PRS 57.71
-
CSI 2.68rCSI 6.81%PRS 56.09
-
CSI 2.66rCSI 2.85%PRS 61.26
-
CSI 2.6rCSI 2.42%PRS 62.44
-
CSI 2.56rCSI 14.65%PRS 71.08
-
CSI 2.47rCSI 1.88%PRS 74.87
-
CSI 2.46rCSI 3.37%PRS 63.51
-
CSI 2.45rCSI 2.41%PRS 77.49
-
CSI 2.45rCSI 2.56%PRS 62.14
-
CSI 2.33rCSI 4.45%PRS 81.45
-
CSI 2.31rCSI 2.05%PRS 59.83
-
CSI 2.29rCSI 3.07%PRS 70.75
-
CSI 2.21rCSI 3.16%PRS 64.12
-
CSI 2.2rCSI 1.67%PRS 75.58
-
CSI 2.16rCSI 1.67%PRS 63.76
-
CSI 2.11rCSI 2.68%PRS 68.33
-
CSI 2.08rCSI 1.64%PRS 68.56
-
CSI 2.06rCSI 1.89%PRS 70.75
-
CSI 2.04rCSI 2.12%PRS 67.53
-
CSI 2.04rCSI 1.79%PRS 67.41
-
CSI 2.01rCSI 3.11%PRS 60.03
-
CSI 2.01rCSI 4.03%PRS 50.92
-
CSI 2rCSI 2.84%PRS 58.18
-
CSI 1.99rCSI 2.09%PRS 58.27
-
CSI 1.98rCSI 1.79%PRS 58.73
-
CSI 1.95rCSI 4.95%PRS 69.88
-
CSI 1.95rCSI 2.34%PRS 59.93
-
CSI 1.95rCSI 4.67%PRS 72.22
-
CSI 1.93rCSI 3.31%PRS 70.71
-
CSI 1.92rCSI 3.42%PRS 75.23
-
CSI 1.9rCSI 2.78%PRS 57.85
-
CSI 1.85rCSI 1.6%PRS 66.84
-
CSI 1.84rCSI 1.58%PRS 67.21
-
CSI 1.82rCSI 1.9%PRS 65.48
-
CSI 1.82rCSI 1.47%PRS 63.29
-
CSI 1.77rCSI 1.4%PRS 48.69
-
CSI 1.77rCSI 1.82%PRS 78.14
-
CSI 1.77rCSI 1.46%PRS 64.07
-
CSI 1.75rCSI 2.42%PRS 62.93
-
CSI 1.74rCSI 4.53%PRS 65.52
-
CSI 1.73rCSI 2.75%PRS 72.92
-
CSI 1.71rCSI 2%PRS 64.2
-
CSI 1.69rCSI 1.63%PRS 52.47
-
CSI 1.68rCSI 1.65%PRS 64.49
-
CSI 1.67rCSI 3.04%PRS 76.99
-
CSI 1.66rCSI 2.43%PRS 66.5
-
CSI 1.65rCSI 4.37%PRS 70.71
-
CSI 1.65rCSI 2.67%PRS 58.45
-
CSI 1.64rCSI 2.52%PRS 70.94
-
CSI 1.64rCSI 12.82%PRS 73.32
-
CSI 1.63rCSI 1.99%PRS 69.32
-
CSI 1.59rCSI 1.97%PRS 58.43
-
CSI 1.58rCSI 1.49%PRS 61.43
-
CSI 1.57rCSI 1.18%PRS 67.33
-
CSI 1.53rCSI 2.27%PRS 67.24
-
CSI 1.53rCSI 1.41%PRS 63.28
-
CSI 1.49rCSI 1.86%PRS 41.71
-
CSI 1.48rCSI 11.79%PRS 70.93
-
CSI 1.48rCSI 0.98%PRS 64.99
-
CSI 1.45rCSI 1.22%PRS 66.17
-
CSI 1.45rCSI 2.09%PRS 72.56
-
CSI 1.43rCSI 2.19%PRS 62.54
-
CSI 1.43rCSI 1.26%PRS 49.69
-
CSI 1.35rCSI 2.42%PRS 60.98
-
CSI 1.33rCSI 1.85%PRS 60.43
-
CSI 1.33rCSI 1.54%PRS 51.92
-
CSI 1.33rCSI 1.77%PRS 68.32
-
CSI 1.28rCSI 1.96%PRS 77.41
-
CSI 1.27rCSI 3.14%PRS 60.26
-
CSI 1.22rCSI 2.23%PRS 53.79
-
CSI 1.21rCSI 1.75%PRS 71.38
-
CSI 1.15rCSI 1.15%PRS 55.1
-
CSI 1.13rCSI 2.13%PRS 72.35
-
CSI 1.12rCSI 0.91%PRS 62.32
-
CSI 1.1rCSI 1.82%PRS 67.07
-
CSI 1.1rCSI 5.52%PRS 74.37
-
CSI 1.09rCSI 1.74%PRS 54.42
-
CSI 0.2rCSI 2.4%PRS 87.7%
-
CSI 0.2rCSI 5.0%PRS 43.5%
-
CSI 0.3rCSI 6.1%PRS 42.7%
-
CSI 0.3rCSI 2.1%PRS 77.9%
-
CSI 0.4rCSI 1.6%PRS 61.4%
-
CSI 0.4rCSI 1.6%PRS 42.0%
-
CSI 0.5rCSI 1.4%PRS 45.3%
-
CSI 0.5rCSI 2.6%PRS 70.8%
-
CSI 0.5rCSI 1.4%PRS 63.2%
-
CSI 0.5rCSI 1.1%PRS 59.8%
-
CSI 0.7rCSI 7.3%PRS 74.2%
-
CSI 0.7rCSI 1.0%PRS 66.1%
-
CSI 0.7rCSI 2.0%PRS 51.6%
-
CSI 0.7rCSI 1.7%PRS 58.2%
-
CSI 0.7rCSI 3.8%PRS 83.3%
-
CSI 0.8rCSI 2.0%PRS 42.3%
-
CSI 0.8rCSI 2.9%PRS 74.3%
-
CSI 0.9rCSI 2.8%PRS 62.2%
-
CSI 0.9rCSI 1.3%PRS 77.9%
-
CSI 1.0rCSI 1.8%PRS 42.7%
-
CSI 1.0rCSI 4.1%PRS 66.7%
-
CSI 1.0rCSI 1.7%PRS 65.6%
-
CSI 1.1rCSI 1.7%PRS 54.4%
-
CSI 1.1rCSI 5.5%PRS 74.4%
-
CSI 1.1rCSI 1.8%PRS 67.1%
-
CSI 1.1rCSI 0.9%PRS 62.3%
-
CSI 1.1rCSI 2.1%PRS 72.4%
-
CSI 1.2rCSI 1.2%PRS 55.1%
-
CSI 1.2rCSI 1.8%PRS 71.4%
-
CSI 1.2rCSI 2.2%PRS 53.8%
-
CSI 1.3rCSI 3.1%PRS 60.3%
-
CSI 1.3rCSI 2.0%PRS 77.4%
-
CSI 1.3rCSI 1.8%PRS 68.3%
-
CSI 1.3rCSI 1.5%PRS 51.9%
-
CSI 1.3rCSI 1.9%PRS 60.4%
-
CSI 1.4rCSI 2.4%PRS 61.0%
-
CSI 1.4rCSI 1.3%PRS 49.7%
-
CSI 1.4rCSI 2.2%PRS 62.5%
-
CSI 1.5rCSI 2.1%PRS 72.6%
-
CSI 1.5rCSI 1.2%PRS 66.2%
-
CSI 1.5rCSI 1.0%PRS 65.0%
-
CSI 1.5rCSI 11.8%PRS 70.9%
-
CSI 1.5rCSI 1.9%PRS 41.7%
-
CSI 1.5rCSI 1.4%PRS 63.3%
-
CSI 1.5rCSI 2.3%PRS 67.2%
-
CSI 1.6rCSI 1.2%PRS 67.3%
-
CSI 1.6rCSI 1.5%PRS 61.4%
-
CSI 1.6rCSI 2.0%PRS 58.4%
-
CSI 1.6rCSI 2.0%PRS 69.3%
-
CSI 1.6rCSI 12.8%PRS 73.3%
-
CSI 1.6rCSI 2.5%PRS 70.9%
-
CSI 1.7rCSI 2.7%PRS 58.5%
-
CSI 1.7rCSI 4.4%PRS 70.7%
-
CSI 1.7rCSI 2.4%PRS 66.5%
-
CSI 1.7rCSI 3.0%PRS 77.0%
-
CSI 1.7rCSI 1.7%PRS 64.5%
-
CSI 1.7rCSI 1.6%PRS 52.5%
-
CSI 1.7rCSI 2.0%PRS 64.2%
-
CSI 1.7rCSI 2.8%PRS 72.9%
-
CSI 1.7rCSI 4.5%PRS 65.5%
-
CSI 1.8rCSI 2.4%PRS 62.9%
-
CSI 1.8rCSI 1.5%PRS 64.1%
-
CSI 1.8rCSI 1.8%PRS 78.1%
-
CSI 1.8rCSI 1.4%PRS 48.7%
-
CSI 1.8rCSI 1.5%PRS 63.3%
-
CSI 1.8rCSI 1.9%PRS 65.5%
-
CSI 1.8rCSI 1.6%PRS 67.2%
-
CSI 1.9rCSI 1.6%PRS 66.8%
-
CSI 1.9rCSI 2.8%PRS 57.9%
-
CSI 1.9rCSI 3.4%PRS 75.2%
-
CSI 1.9rCSI 3.3%PRS 70.7%
-
CSI 2.0rCSI 4.7%PRS 72.2%
-
CSI 2.0rCSI 2.3%PRS 59.9%
-
CSI 2.0rCSI 5.0%PRS 69.9%
-
CSI 2.0rCSI 1.8%PRS 58.7%
-
CSI 2.0rCSI 2.1%PRS 58.3%
-
CSI 2.0rCSI 2.8%PRS 58.2%
-
CSI 2.0rCSI 4.0%PRS 50.9%
-
CSI 2.0rCSI 3.1%PRS 60.0%
-
CSI 2.0rCSI 1.8%PRS 67.4%
-
CSI 2.0rCSI 2.1%PRS 67.5%
-
CSI 2.1rCSI 1.9%PRS 70.8%
-
CSI 2.1rCSI 1.6%PRS 68.6%
-
CSI 2.1rCSI 2.7%PRS 68.3%
-
CSI 2.2rCSI 1.7%PRS 63.8%
-
CSI 2.2rCSI 1.7%PRS 75.6%
-
CSI 2.2rCSI 3.2%PRS 64.1%
-
CSI 2.3rCSI 3.1%PRS 70.8%
-
CSI 2.3rCSI 2.1%PRS 59.8%
-
CSI 2.3rCSI 4.5%PRS 81.5%
-
CSI 2.5rCSI 2.6%PRS 62.1%
-
CSI 2.5rCSI 2.4%PRS 77.5%
-
CSI 2.5rCSI 3.4%PRS 63.5%
-
CSI 2.5rCSI 1.9%PRS 74.9%
-
CSI 2.6rCSI 14.7%PRS 71.1%
-
CSI 2.6rCSI 2.4%PRS 62.4%
-
CSI 2.7rCSI 2.9%PRS 61.3%
-
CSI 2.7rCSI 6.8%PRS 56.1%
-
CSI 2.7rCSI 4.2%PRS 57.7%
-
CSI 2.7rCSI 4.4%PRS 51.4%
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration
Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.
Legend:
- Query Gene
-
Node Color (Target Cell CSI, relative to current network):
- Very High
- High
- Medium
- Low
- Very Low
- CSI N/A
- Node Size: Proportional to Target Cell CSI magnitude
- STRING PPI Edge
- Shared Pathway Edge (ONTOLOGY)
Other Information
This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.
Genular Protein ID: 174947742
Symbol: NIT2_HUMAN
Name: Omega-amidase NIT2
UniProtKB Accession Codes:
Database IDs:
Citations:
PubMed ID: 10959838
Title: Crystal structure of the worm NitFhit Rosetta stone protein reveals a Nit tetramer binding two Fhit dimers.
PubMed ID: 10959838
PubMed ID: 14702039
Title: Complete sequencing and characterization of 21,243 full-length human cDNAs.
PubMed ID: 14702039
DOI: 10.1038/ng1285
PubMed ID: 15489334
Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
PubMed ID: 15489334
DOI: 10.1101/gr.2596504
PubMed ID: 14528910
Title: Deranged hypothetical proteins Rik protein, Nit protein 2 and mitochondrial inner membrane protein, Mitofilin, in fetal Down syndrome brain.
PubMed ID: 14528910
PubMed ID: 15592455
Title: Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.
PubMed ID: 15592455
DOI: 10.1038/nbt1046
PubMed ID: 17488281
Title: Growth inhibitory effect of the human NIT2 gene and its allelic imbalance in cancers.
PubMed ID: 17488281
PubMed ID: 19595734
Title: Identification of the putative tumor suppressor Nit2 as omega-amidase, an enzyme metabolically linked to glutamine and asparagine transamination.
PubMed ID: 19595734
PubMed ID: 21269460
Title: Initial characterization of the human central proteome.
PubMed ID: 21269460
PubMed ID: 22674578
Title: Structural insights into the catalytic active site and activity of human Nit2/omega-amidase: kinetic assay and molecular dynamics simulation.
PubMed ID: 22674578
PubMed ID: 24275569
Title: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.
PubMed ID: 24275569
PubMed ID: 25944712
Title: N-terminome analysis of the human mitochondrial proteome.
PubMed ID: 25944712
Sequence Information:
- Length: 276
- Mass: 30608
- Checksum: 32FA797601A419C6
- Sequence:
MTSFRLALIQ LQISSIKSDN VTRACSFIRE AATQGAKIVS LPECFNSPYG AKYFPEYAEK IPGESTQKLS EVAKECSIYL IGGSIPEEDA GKLYNTCAVF GPDGTLLAKY RKIHLFDIDV PGKITFQESK TLSPGDSFST FDTPYCRVGL GICYDMRFAE LAQIYAQRGC QLLVYPGAFN LTTGPAHWEL LQRSRAVDNQ VYVATASPAR DDKASYVAWG HSTVVNPWGE VLAKAGTEEA IVYSDIDLKK LAEIRQQIPV FRQKRSDLYA VEMKKP